INKT MiNK Therapeutics, Inc.
Fundamentals / CIK 0001840229 / USDMiNK Therapeutics, Inc. reported $8.24M in total assets and a net loss of $11.02M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open INKT in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$11.44M Operating profit
-
Net Income FY 2025-$11.02M GAAP bottom line
-
Diluted EPS FY 2025-$2.16 Split-adjusted
-
Free Cash Flow FY 2025-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$7.47M Total debt: --
Annual revenue and net income
6 fiscal years (2020 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Research & Development | $5.76M | $6.34M | $15.49M | $23.12M | $13.97M | $9.51M |
| Operating Income | -$12.64M | -$11.29M | -$22.92M | -$30.95M | -$28.36M | -$14.64M |
| EBITDA | -$12.46M | -$11.07M | -$22.72M | -$30.83M | -$28.28M | -$14.58M |
| Interest Expense | -$110K | -$93K | -$28K | -- | $2.43M | $2.44M |
| Net Income | -$12.49M | -$10.78M | -$22.46M | -$27.99M | -$30.21M | -$16.24M |
| Basic EPS | -$2.93 | -$2.86 | -$6.54 | -$8.30 | -$11.60 | -$6.70 |
| Diluted EPS | -$2.93 | -$2.86 | -$6.54 | -$8.30 | -$11.60 | -$6.70 |
| Basic Shares Outstanding | 4.3M | 3.8M | 3.4M | 3.4M | 2.6M | 2.4M |
| Diluted Shares Outstanding | 4.3M | 3.8M | 3.4M | 3.4M | 2.6M | 2.4M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $200K | -- | -- | -- | $0 | -- | -- | -- |
| Research & Development | $1.80M | $1.89M | $1.20M | $1.51M | $1.14M | $1.84M | $1.26M | $1.41M |
| Operating Income | -$2.64M | -$3.22M | -$2.88M | -$2.71M | -$3.18M | -$4.05M | -$2.70M | -$2.50M |
| EBITDA | -$2.60M | -$3.18M | -$2.85M | -$2.67M | -$3.14M | -$4.00M | -$2.65M | -$2.45M |
| Interest Expense | -$1.0K | -$2.0K | -$4.0K | -$29K | -$25K | -$27K | -$29K | -$30K |
| Net Income | -$2.55M | -$3.13M | -$2.74M | -$2.60M | -$2.89M | -$4.24M | -$2.77M | -$2.46M |
| Basic EPS | -$0.50 | -$0.62 | -$0.57 | -- | -$0.65 | -$1.06 | -$0.70 | -- |
| Diluted EPS | -$0.50 | -$0.62 | -$0.57 | -- | -$0.65 | -$1.06 | -$0.70 | -- |
| Basic Shares Outstanding | 5.1M | 5.0M | 4.8M | -- | 4.4M | 4.0M | 4.0M | -- |
| Diluted Shares Outstanding | 5.1M | 5.0M | 4.8M | -- | 4.4M | 4.0M | 4.0M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $13.36M | $4.58M | $3.37M | $19.64M | $38.89M | $2.69M |
| Cash & Short-Term Investments | $13.36M | $4.58M | $3.37M | $19.64M | $38.89M | $2.69M |
| Other Current Assets | $211K | $164K | $178K | $470K | $744K | $914K |
| Total Current Assets | $13.85M | $4.99M | $3.60M | $20.40M | $39.63M | $4.10M |
| Property, Plant & Equipment, Net | $391K | $733K | $954K | $1.07M | $607K | $458K |
| Total Non-Current Assets | $391K | $733K | $954K | $1.07M | $607K | $458K |
| Total Assets | $14.24M | $5.72M | $4.55M | $21.47M | $40.24M | $4.56M |
| Accounts Payable | $3.43M | $2.73M | $3.91M | $5.82M | $3.00M | $3.14M |
| Other Current Liabilities | $2.85M | $2.36M | $2.45M | $2.62M | $5.76M | $5.69M |
| Total Current Liabilities | $13.03M | $6.96M | $11.40M | $12.68M | $16.47M | $14.22M |
| Other Non-Current Liabilities | -- | $0 | $48K | $108K | -- | $383K |
| Total Non-Current Liabilities | $15.44M | $18.35M | $11.21M | $9.19M | $0 | $44.21M |
| Total Liabilities | $28.47M | $25.31M | $22.61M | $21.87M | $16.47M | $58.43M |
| Common Stock | $48 | $40 | $35 | $339 | $335 | $242 |
| Retained Earnings | -$156.7M | -$144.2M | -$133.4M | -$110.9M | -$82.95M | -$52.74M |
| Accumulated Other Comp. Income | -$719K | -$632K | -$431K | -$292K | -$625K | -$1.52M |
| Total Stockholders' Equity | -$14.23M | -$19.59M | -$18.06M | -$401K | $23.78M | -$53.87M |
| Total Equity | -$14.23M | -$19.59M | -$18.06M | -$401K | $23.78M | -$53.87M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $7.47M | $8.81M | $9.53M | $13.36M | $9.50M | $1.68M | $3.23M | $4.58M |
| Cash & Short-Term Investments | $7.47M | $8.81M | $9.53M | $13.36M | $9.50M | $1.68M | $3.23M | $4.58M |
| Other Current Assets | $85K | $212K | $232K | $211K | $32 | $55K | $109K | $164K |
| Total Current Assets | $7.90M | $9.30M | $10.02M | $13.85M | $14.53M | $2.01M | $3.58M | $4.99M |
| Property, Plant & Equipment, Net | $339K | $318K | $355K | $391K | $429K | $473K | $688K | $733K |
| Total Non-Current Assets | $339K | $318K | $355K | $391K | $429K | $473K | $688K | $733K |
| Total Assets | $8.24M | $9.62M | $10.38M | $14.24M | $14.96M | $2.48M | $4.27M | $5.72M |
| Accounts Payable | $4.49M | $3.92M | $3.39M | $3.43M | $3.69M | $3.31M | $2.66M | $2.73M |
| Other Current Liabilities | $2.37M | $2.45M | $2.57M | $2.85M | $2.76M | $2.48M | $2.37M | $2.36M |
| Total Current Liabilities | $8.18M | $7.57M | $7.29M | $13.03M | $13.43M | $13.16M | $12.12M | $6.96M |
| Other Non-Current Liabilities | -- | -- | -- | -- | -- | -- | -- | $0 |
| Total Non-Current Liabilities | $16.32M | $16.07M | $15.78M | $15.44M | $15.04M | $14.51M | $13.94M | $18.35M |
| Total Liabilities | $24.49M | $23.64M | $23.06M | $28.47M | $28.48M | $27.67M | $26.06M | $25.31M |
| Common Stock | $52 | $52 | $51 | $48 | $46 | $40 | $40 | $40 |
| Retained Earnings | -$165.1M | -$162.5M | -$159.4M | -$156.7M | -$154.1M | -$151.2M | -$146.9M | -$144.2M |
| Accumulated Other Comp. Income | -$704K | -$700K | -$697K | -$719K | -$692K | -$719K | -$662K | -$632K |
| Total Stockholders' Equity | -$16.25M | -$14.03M | -$12.69M | -$14.23M | -$13.51M | -$25.19M | -$21.79M | -$19.59M |
| Total Equity | -$16.25M | -$14.03M | -$12.69M | -$14.23M | -$13.51M | -$25.19M | -$21.79M | -$19.59M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Net Income | -$12.49M | -$10.78M | -$22.46M | -$27.99M | -$30.21M | -$16.24M |
| Depreciation & Amortization | $182K | $215K | $205K | $122K | $78K | $55K |
| Stock-Based Compensation | $2.67M | $1.81M | $3.86M | $3.03M | $1.74M | $88K |
| Change in Payables | $690K | -$1.18M | -$1.92M | $2.66M | -$152K | $608K |
| Operating Cash Flow | -$5.93M | -$9.56M | -$15.76M | -$18.87M | -$12.83M | -$8.34M |
| Capital Expenditure | -- | -- | -$74K | -$250K | -$249K | -$95K |
| Free Cash Flow | -- | -- | -$15.84M | -$19.12M | -$13.08M | -$8.43M |
| Investing Cash Flow | -- | -- | -$74K | -$250K | -$249K | -$95K |
| Common Stock Issued | $14.45M | -- | -- | -- | -- | -- |
| Financing Cash Flow | $14.72M | $10.82M | -$407K | -$156K | $49.26M | $11.11M |
| Net Change in Cash | $8.78M | $1.21M | -$16.27M | -$19.25M | $36.20M | $2.39M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$2.55M | -$3.13M | -$2.74M | -$2.60M | -$2.89M | -$4.24M | -$2.77M | -$2.46M |
| Depreciation & Amortization | $36K | $36K | $36K | $39K | $44K | $49K | $51K | $54K |
| Stock-Based Compensation | $333K | $422K | $630K | $566K | $621K | $897K | $591K | $390K |
| Change in Payables | $570K | $527K | -$32K | -$270K | $382K | $646K | -$69K | $374K |
| Operating Cash Flow | -$1.28M | -$2.08M | -$1.73M | -$2.07M | -$941K | -$1.57M | -$1.34M | -$1.73M |
| Common Stock Issued | $0 | $1.37M | $3.02M | -- | -- | -- | -- | -- |
| Financing Cash Flow | $0 | $1.37M | -$2.10M | $1.18M | $13.55M | $540 | $576 | -$3 |
| Net Change in Cash | -$1.34M | -$719K | -$3.83M | -$921K | $12.60M | -$1.55M | -$1.34M | -$1.75M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -- | -- | -- | -- | -127.1% | -- |
| Return on Assets (ROA) | -87.7% | -188.5% | -493.3% | -130.4% | -75.1% | -356.5% |
| Current Ratio | 1.06x | 0.72x | 0.32x | 1.61x | 2.41x | 0.29x |
| Quick Ratio | 1.03x | 0.66x | 0.30x | 1.55x | 2.36x | 0.19x |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Assets (ROA) | -133.7% | -118.1% | -120.2% | -87.7% | -82.6% | -453.8% | -228.2% | -188.5% |
| Current Ratio | 0.97x | 1.23x | 1.38x | 1.06x | 1.08x | 0.15x | 0.30x | 0.72x |
| Quick Ratio | 0.91x | 1.16x | 1.31x | 1.03x | 0.71x | 0.13x | 0.27x | 0.66x |